The Impact of Opioids in Coronary Heart Disease (MIOP/TRAPS)

Ruhr University of Bochum

Status: Completed

Conditions: Coronary Heart Disease

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02740621

MIOP

Details and patient eligibility

About

In this study, the risk of opioid medications on coronary heart disease in adults is investigated. Patients with the necessity of a coronary angiography and control patients with a non-cardiac disease of the same hospital are inquired with a standardized questionnaire about demographic and clinical risk factors for heart attack. An impact of opioid medications on coronary heart disease is hypothesised (MIOP).

In addition, all patients with coronary angiography should be consulted twice (after 3 and 6 months) to find out how many of these patients have developed a refractory angina pectoris (TRAPS).

Enrollment: 750 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 40 years or older
• written informed consent

Exclusion criteria

• currently cancer
• cognitive limitations

Trial design

750 participants in 2 patient groups

Patients with coronary heart disease

Description:

coronary angiography with finding coronary heart disease currently no cancer 40 years or older

control patients

Description:

coronary angiography with exclusion coronary heart disease or other patients with non-cardiac diseases currently no cancer 40 years or older